| Megan Ferguson, CNM | |
|
2490 S Woodworth Loop, Suite 301, Palmer, AK 99645-7410 | |
| (907) 746-7747 | |
| (907) 746-7731 |
| Full Name | Megan Ferguson |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 8 Years |
| Location | 2490 S Woodworth Loop, Palmer, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487017877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Network Of Alaska Llc | 3072618859 | 61 |
News Archive
New research shows that rural emergency room physicians are increasingly using videoconferences to gain access to specialty care.
According to the latest research new hormone therapy drugs designed to treat breast cancer may dispense with the need for chemotherapy thus avoiding the nasty side effects associated with the treatment.
Once hailed as a breakthrough in cancer treatment, immunotherapies are now raising concerns as doctors note new side effects like severe allergic reactions, acute-onset diabetes and heart damage.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
Tumor necrosis factor-alpha is a widely accepted biomarker for cancer, but the minute amounts of this protein circulating in blood makes detecting the molecule and measuring its concentration accurately a technological challenge.
› Verified 2 days ago
| Entity Name | Medical Network Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538414834 PECOS PAC ID: 3072618859 Enrollment ID: O20070424000329 |
News Archive
New research shows that rural emergency room physicians are increasingly using videoconferences to gain access to specialty care.
According to the latest research new hormone therapy drugs designed to treat breast cancer may dispense with the need for chemotherapy thus avoiding the nasty side effects associated with the treatment.
Once hailed as a breakthrough in cancer treatment, immunotherapies are now raising concerns as doctors note new side effects like severe allergic reactions, acute-onset diabetes and heart damage.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
Tumor necrosis factor-alpha is a widely accepted biomarker for cancer, but the minute amounts of this protein circulating in blood makes detecting the molecule and measuring its concentration accurately a technological challenge.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Ferguson, CNM 2490 S Woodworth Loop, Suite 301, Palmer, AK 99645-7410 Ph: (907) 746-7747 | Megan Ferguson, CNM 2490 S Woodworth Loop, Suite 301, Palmer, AK 99645-7410 Ph: (907) 746-7747 |
News Archive
New research shows that rural emergency room physicians are increasingly using videoconferences to gain access to specialty care.
According to the latest research new hormone therapy drugs designed to treat breast cancer may dispense with the need for chemotherapy thus avoiding the nasty side effects associated with the treatment.
Once hailed as a breakthrough in cancer treatment, immunotherapies are now raising concerns as doctors note new side effects like severe allergic reactions, acute-onset diabetes and heart damage.
Champions Biotechnology, Inc., a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the fiscal year ended April 30, 2010.
Tumor necrosis factor-alpha is a widely accepted biomarker for cancer, but the minute amounts of this protein circulating in blood makes detecting the molecule and measuring its concentration accurately a technological challenge.
› Verified 2 days ago
Ms. Rose M Williams, CNM,ANP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 10425 E Bradley Lake Ave, Palmer, AK 99645 Phone: 907-746-4005 |